Developed by Life-Science Innovations (LSI) in conjunction with Epitopix, Select Genetics provides the first sustained-release vaccine platform. The SRV allows day-of-age vaccinations to be administered and then proceeds over several weeks to release antigens as each bird's immune system matures. This ultimately ensures a strong immune response to these antigens. Currently, Select Genetics can offer this protection against E. coli and Hemorrhagic Enteritis (HE) with additional products against Newcastle and Bordetella underway.